Tremfya (Guselkumab) is a biological medication used for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. It provides long-lasting relief by targeting key immune pathways responsible for inflammation.
The active ingredient, Guselkumab, is a monoclonal antibody that specifically blocks the IL-23 protein, helping to reduce inflammation, skin scaling, and joint pain.
Key Features:
Effective treatment for psoriasis and psoriatic arthritis.
Suitable for patients unresponsive to topical or conventional therapy.
Improves skin condition and joint mobility.
Administered via subcutaneous injection.
Dosage & Administration:
Initial dose: 100 mg subcutaneously at week 0 and week 4.
Maintenance: 100 mg every 8 weeks thereafter.
Can be administered under medical supervision or via self-injection (after training).
Warnings & Precautions:
Not to be used in patients with active infections.
Inform your doctor about any chronic conditions or symptoms.
Use with caution during pregnancy or breastfeeding.
Storage:
Store in a refrigerator at 2–8°C (36–46°F).
Do not freeze.
Allow to reach room temperature for 30 minutes before injection.
Reviews
There are no reviews yet.